Abstract

Genome-wide association studies have identified thousands of loci associated with common diseases and traits. However, a large fraction of heritability remains unexplained. Epigenetic modifications, such as the observed in DNA methylation have been proposed as a mechanism of intergenerational inheritance. To investigate the potential contribution of DNA methylation to the missing heritability, we analysed the methylomes of four healthy trios (two parents and one offspring) using whole genome bisulphite sequencing. Of the 1.5 million CpGs (19%) with over 20% variability between parents in at least one family and compatible with a Mendelian inheritance pattern, only 3488 CpGs (0.2%) lacked correlation with any SNP in the genome, marking them as potential sites for intergenerational epigenetic inheritance. These markers were distributed genome-wide, with some preference to be located in promoters. They displayed a bimodal distribution, being either fully methylated or unmethylated, and were often found at the boundaries of genomic regions with high/low GC content. This analysis provides a starting point for future investigations into the missing heritability of simple and complex traits.

Details

Title
Identification of intergenerational epigenetic inheritance by whole genome DNA methylation analysis in trios
Author
Díez-Villanueva, Anna 1 ; Martín, Berta 2 ; Moratalla-Navarro, Ferran 3 ; Morón-Duran, Francisco D. 4 ; Galván-Femenía, Iván 5 ; Obón-Santacana, Mireia 1 ; Carreras, Anna 5 ; de Cid, Rafael 5 ; Peinado, Miguel A. 2 ; Moreno, Victor 3   VIAFID ORCID Logo 

 Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Barcelona, Spain (GRID:grid.418701.b) (ISNI:0000 0001 2097 8389); ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain (GRID:grid.418284.3) (ISNI:0000 0004 0427 2257); Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246) 
 Germans Trias i Pujol Institute (IGTP), Translational Program in Cancer Research (CARE), Badalona, Spain (GRID:grid.429186.0) (ISNI:0000 0004 1756 6852) 
 Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Barcelona, Spain (GRID:grid.418701.b) (ISNI:0000 0001 2097 8389); ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain (GRID:grid.418284.3) (ISNI:0000 0004 0427 2257); Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain (GRID:grid.466571.7) (ISNI:0000 0004 1756 6246); University of Barcelona, Department of Clinical Sciences, Faculty of Medicine and Universitat de Barcelona Institute of Complex Systems (UBICS), Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247) 
 Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Barcelona, Spain (GRID:grid.418701.b) (ISNI:0000 0001 2097 8389); ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain (GRID:grid.418284.3) (ISNI:0000 0004 0427 2257); University of Barcelona, Department of Clinical Sciences, Faculty of Medicine and Universitat de Barcelona Institute of Complex Systems (UBICS), Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247) 
 Germans Trias i Pujol Research Institute (IGTP), Genomes for Life-GCAT lab., Badalona, Spain (GRID:grid.429186.0) (ISNI:0000 0004 1756 6852) 
Pages
21266
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2896129415
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.